First Tracks Biotherapeutics Inc
TRAX
NASDAQ
Biotechnology
$44.04
USD
+0.01 (+0.02%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.54B
Volume 446.2K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
BCAX | Bicara Therapeutics Inc | $1.82B | - | - | - | |
ZYME | Zymeworks Inc | $1.79B | - | +3.3% | - | |
RXRX | Recursion Pharmaceuticals Inc | $1.78B | - | -15.1% | - | |
XNCR | Xencor Inc | $1.70B | - | -33.2% | - | |
NTLA | Intellia Therapeutics Inc | $1.67B | - | +12.6% | - | |
ABSI | Absci Corp | $1.62B | - | -61.9% | - | |
FBRX | Forte Biosciences Inc | $1.57B | - | -99.8% | - | |
TRAX | First Tracks Biotherapeutics Inc | $1.54B | - | - | - | |
JBIO | Jade Biosciences Inc | $1.51B | - | - | - | |
VIR | Vir Biotechnology Inc | $1.50B | - | +1496.1% | - | |
TYRA | Tyra Biosciences Inc | $1.49B | - | - | - |
Top Peer by Growth
Vir Biotechnology Inc
+1496.1% YoY Revenue
Best 1-Year Return
Forte Biosciences Inc
+627.1% Return